Literature DB >> 10502320

Distinct chromosome 3 abnormalities in persistent polyclonal B-cell lymphocytosis.

E Callet-Bauchu1, S Gazzo, C Poncet, J Pagès, D Morel, C Alliot, B Coiffier, P Coeur, G Salles, P Felman.   

Abstract

Persistent polyclonal B-cell lymphocytosis (PPBL) is a rare entity of unknown etiology characterized by a polyclonal expansion of B-lymphocytes with typical bilobulated forms, elevated serum IgM, and an additional isochromosome for the long arm of chromosome 3 as the sole change. In the present study, we investigated four cases of PPBL by means of conventional cytogenetic analysis and FISH. In all patients, the polyclonality of the lymphoproliferation was demonstrated by immunophenotypic studies, and PCR analysis failed to demonstrate clonal IGH rearrangements in three evaluated cases. In two patients, in addition to +i(3)(q10), banding techniques identified unrelated clones with trisomy 3. FISH studies using a chromosome 3 long arm-specific probe provided evidence that all cases had both +i(3)(q10) and +3. To determine more precisely the distribution of the chromosomal abnormalities within the peripheral lymphocyte population, we investigated two of these cases using a technique of simultaneous fluorescence immunophenotyping and interphase cytogenetics (FICTION). We demonstrated that both abnormalities were randomly distributed among the B-lymphocytes, independently of the kappa or lambda light chain isotype and the nuclear aspect. These data lead us to conclude that trisomy 3 represents, in addition to +i(3)(q10), another recurrent cytogenetic change in PPBL, suggesting that this lymphoproliferative disorder is associated with an increased frequency of chromosome 3 instability. Copyright 1999 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10502320     DOI: 10.1002/(sici)1098-2264(199911)26:3<221::aid-gcc6>3.0.co;2-9

Source DB:  PubMed          Journal:  Genes Chromosomes Cancer        ISSN: 1045-2257            Impact factor:   5.006


  6 in total

1.  Early lesions in lymphoid neoplasia: Conclusions based on the Workshop of the XV. Meeting of the European Association of Hematopathology and the Society of Hematopathology, in Uppsala, Sweden.

Authors:  Falko Fend; José Cabecadas; Philippe Gaulard; Elaine S Jaffe; Philip Kluin; Isinsu Kuzu; Loann Peterson; Andrew Wotherspoon; Christer Sundström
Journal:  J Hematop       Date:  2012-09       Impact factor: 0.196

2.  B-cell signaling in persistent polyclonal B lymphocytosis (PPBL).

Authors:  Nadine Voelxen; Claudia Wehr; Sylvia Gutenberger; Baerbel Keller; Miriam Erlacher; Cecilia Dominguez-Conde; Daniela Bertele; Florian Emmerich; Milena Pantic; Stefanie Jennings; Mirzokhid Rakhmanov; Christian Foerster; Uwe M Martens; Uwe Platzbecker; Hans-Hartmut Peter; Paul Fisch; Kaan Boztug; Hermann Eibel; Ulrich Salzer; Klaus Warnatz
Journal:  Immunol Cell Biol       Date:  2016-04-29       Impact factor: 5.126

3.  [Asymptomatic 32 year old female smoker with persistent polyclonal lymphocytosis].

Authors:  B Chapuy; G Wulf; H W Tessen; F Griesinger; L Trümper; R Schroers
Journal:  Internist (Berl)       Date:  2007-03       Impact factor: 0.743

4.  Polyclonal B-cell lymphocytosis with binucleated lymphocytes (PPBL).

Authors:  Xavier Troussard; Edouard Cornet; Jean-François Lesesve; Carine Kourel; Hossein Mossafa
Journal:  Onco Targets Ther       Date:  2008-10-01       Impact factor: 4.147

5.  Successful Pregnancy and Persistent Polyclonal B Cell Lymphocytosis (PPBL): A Case Study of a Rare Co-Existence.

Authors:  Georgios Dryllis; Theofanis Giannikos; Eliana A Konstantinou; Ioannis Moustakas; Panagiotis Christopoulos; Theodoros Pittaras; Marianna Politou; Serena Valsami
Journal:  Am J Case Rep       Date:  2021-12-22

Review 6.  Histological and immunohistochemical features of the spleen in persistent polyclonal B-cell lymphocytosis closely mimic splenic B-cell lymphoma.

Authors:  Ping Sun; Ridas Juskevicius
Journal:  Diagn Pathol       Date:  2012-08-19       Impact factor: 2.644

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.